NCT04448106View on ClinicalTrials.gov

Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 15, 2026

Conditions
Osteoarthritis, KneeOsteoarthritis, HipOsteoarthritis Shoulder
Interventions
BIOLOGICAL

Celltex- AdMSCs

Autologous adipose-derived stem cells Culture expanded mesenchymal stem cells isolated from a patient's own abdominal fat tissue

Trial Locations (1)

77098

Stanley C Jones, Houston

Sponsors
All Listed Sponsors
lead

Celltex Therapeutics Corporation

INDUSTRY